comparemela.com

Latest Breaking News On - கோட்டை க்ரீக் உயிர் அறிவியல் இன்க் - Page 1 : comparemela.com

First Trust IPOX-100 Index Fund ETF (ETF:FPX), (IPO) - Skin-Disease Focused Biotech Castle Creek Files $100M IPO

First Trust IPOX-100 Index Fund ETF (ETF:FPX), (IPO) - Skin-Disease Focused Biotech Castle Creek Files $100M IPO
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

North America Cell Therapy Markets, 2021-2027 - Growing Collaborative Efforts to Promote Cell Therapy & Developments in Cell Therapy Against COVID-19

North America Cell Therapy Markets, 2021-2027 - Growing Collaborative Efforts to Promote Cell Therapy & Developments in Cell Therapy Against COVID-19
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Forge Biologics Expands Gene Therapy Leadership Team with Appointment of John Maslowski as Chief Commercial Officer

Published: Jun 03, 2021     COLUMBUS, Ohio (BUSINESS WIRE) Forge Biologics, a gene therapy-focused contract development and manufacturing organization (CDMO), announced today the appointment of John Maslowski to the newly created role of Chief Commercial Officer. Mr. Maslowski brings significant gene therapy manufacturing and development experience to Forge as the Company has expanded its cGMP AAV manufacturing capabilities, including process and analytical development. As CCO, Mr. Maslowski will lead the Marketing, Sales, and Client Development departments to support our partners and clients on their path towards commercializing gene therapies. John Maslowski, Chief Commercial Officer (Photo: Business Wire) “We are excited to have John join the leadership team at such an important inflection point in the growth of Forge,” said Timothy J. Miller, Ph.D., CEO, President and Co-Founder of Forge Biologics. “John is a seasoned biotech executive, bringing over 20 years o

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.